Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 7Recruiting 5Not yet recruiting 3Active not recruiting 3Unknown 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 11Breast 3Thoracic 2Plasma cell 2Lymphoid 2Gynecologic 2Genitourinary 2Other neoplasm 1Other hematologic neoplasm 1Head & Neck 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cyclophosphamide 137Rituximab 112Etoposide 77Vincristine 74Doxorubicin 61Cytarabine 61Dexamethasone 58Prednisone 54fludarabine 52Methotrexate 46N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 42Lenalidomide 36Gemcitabine 35Radiotherapy 29Melphalan 27pegaspargase 22Prednisolone 22Ifosfamide 22Busulfan 20fludarabine phosphate 19Cisplatin 19Bendamustine Hydrochloride 19Asparaginase 18Peripheral Blood Stem Cell Transplantation 17Carmustine 16ibrutinib 15Mercaptopurine 15Filgrastim 15Decitabine 15Oxaliplatin 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Observation × Lymphoid × Clear all
NCT05729178 2024-03-25

Unravelling the Role of KCTD Protein Family in the Clinical Management of Childhood Acute Lymphoblastic Leukemias

IRCCS SYNLAB SDN

Unknown
80 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03016000 2017-07-28

Thalidomide Maintenance Treatment in DLBCL

Nanfang Hospital, Southern Medical University

Phase 3 Unknown
226 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡